Literature DB >> 7056233

D-2 dopamine receptor-mediated inhibition of adenylate cyclase activity in the intermediate lobe of the rat pituitary gland requires guanosine 5'-triphosphate.

T E Cote, C W Grewe, K Tsuruta, J C Stoof, R L Eskay, J W Kebabian.   

Abstract

After treatment with cholera toxin, homogenates of intact intermediate lobe (IL) tissue of rat pituitary gland synthesized more cAMP than did homogenates of untreated IL tissue, and only in the presence of GTP did dopamine or apomorphine diminish the elevated adenylate cyclase activity in homogenates of cholera toxin-treated IL tissue. Furthermore, when tested on cholera toxin-treated IL tissue, 5'-guanylyl imidodiphosphate [Gpp(NH)p] and two other nonhydrolyzable analogs of GTP inhibited adenylate cyclase activity in the absence of either a dopaminergic agonist or GTP; GTP reversed the Gpp(NH)p-induced inhibition of adenylate cyclase activity. Apomorphine, a dopaminergic agonist, abolished the ability of GTP to reverse the inhibition by Gpp(NH)p; this effect of apomorphine was prevented by fluphenazine, a dopaminergic antagonist. Sodium fluoride inhibited adenylate cyclase activity to approximately the same level obtained with GTP and apomorphine. In addition, apomorphine decreased cAMP accumulation and alpha MSH release from dispersed IL cells pretreated with cholera toxin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7056233     DOI: 10.1210/endo-110-3-812

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

1.  Neurochemical and behavioural evidence that dopamine D-2 receptors in striatum couple to the Ni regulatory protein and inhibition of cyclic AMP accumulation.

Authors:  E Kelly; A L Willcocks; S R Nahorski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-06       Impact factor: 3.000

2.  Prolactin unresponsiveness to repeated sulpiride administration in man: recent findings.

Authors:  G P Bernini; M Gasperi; G Gravina; M S Vivaldi; C Del Corso; R Santoni; M Luisi; F Franchi
Journal:  J Endocrinol Invest       Date:  1987-04       Impact factor: 4.256

3.  Possible mechanism of prolactin unresponsiveness to repeated sulpiride administration in man.

Authors:  G P Bernini; M Gasperi; M S Vivaldi; R Santoni; M Luisi; F Franchi
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

4.  Mechanism of dopamine mediated inhibition of neuropeptide Y release from pheochromocytoma cells (PC12 cells).

Authors:  Guihua Cao; Alice Gardner; Thomas C Westfall
Journal:  Biochem Pharmacol       Date:  2007-01-07       Impact factor: 5.858

5.  Dopamine D2 receptor stimulation alters G-protein expression in rat pituitary intermediate lobe melanotropes.

Authors:  S A Sands; D S Dickerson; S J Morris; B M Chronwall
Journal:  Endocrine       Date:  1997-06       Impact factor: 3.633

6.  Unresponsiveness of prolactin to repeated injection of sulpiride in man.

Authors:  H Cohen; M Pugeat; J Tourniaire; J Bertrand
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Occurrence of a hormone-sensitive inhibitory coupling component of the adenylate cyclase in S49 lymphoma cyc- variants.

Authors:  K H Jakobs; G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

8.  Ca2+ current expression in pituitary melanotrophs of neonatal rats and its regulation by D2 dopamine receptors.

Authors:  J C Gomora; G Avila; G Cota
Journal:  J Physiol       Date:  1996-05-01       Impact factor: 5.182

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.